OPS „Tabakentwöhnung“ im DRG-System – eine lohnende Perspektive für Patienten und Klinik

• Literatur

• 1 Murray CJ, Richards MA, Newton JN. et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997-1020 doi:10.1016/S0140-6736(13)60355-4.
• 2 Pirie K, Peto R, Reeves GK. et al. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013; 381: 133-141 doi:10.1016/S0140-6736(12)61720-6.
• 3 Vogelmeier CF, Criner GJ, Martinez FJ. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 2017; 195: 557-582
• 4 Andreas S, Batra A, Behr J. et al. [Smoking cessation in patients with COPD]. Pneumologie 2014; 68: 237-258 doi: 10.1055/s-0034-1365052
• 5 Perk J, De Backer G, Gohlke H. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701 doi:10.1093/eurheartj/ehs092.
• 6 Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003 doi:10.1093/eurheartj/eht296.
• 7 Rigotti NA. et al. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 16.05.2012; CD001837 doi:10.1002/14651858.CD001837.pub3
• 8 Rice VH, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev 2004; CD001188 doi:10.1002/14651858.CD001188.pub2
• 9 Lai DT. et al. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 20.01.2010; CD006936 doi:10.1002/14651858.CD006936.pub2
• 10 Kahn R, Robertson RM, Smith R. et al. The impact of prevention on reducing the burden of cardiovascular disease. Circulation 2008; 118: 576-585 doi:10.1161/CIRCULATIONAHA.108.190186
• 11 Hoogendoorn M, Feenstra TL, Hoogenveen RT. et al. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax 2010; 65: 711-718 doi:10.1136/thx.2009.131631
• 12 Lewis K, Stern M. British Thoracic Society Recommendations for Hospital Smoking Cessation Services for Commissioners and Health Care Professionals. British Thoracic Society Reports 2012; 4: 1-17 ISSN 2040-2023
• 13 Atsou K, Chouaid C, Hejblum G. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease. PLoS One 2011; 6: e24870 doi:10.1371/journal.pone.0024870.
• 14 Lang K, Wasem J, Aidelsburger P. Cost-effectiveness of Nicotine Replacement Therapy (NRT) in patients with Chronic Obstructive Pulmonary Disease (COPD): A decision-analytic model. PharmacoEconomics German Research Articles 2008; 6: 111-123
• 15 Koskenvuo K, Broms U, Korhonen T. et al. Smoking strongly predicts disability retirement due to COPD: the Finnish Twin Cohort Study. Eur Respir J 2011; 37: 26-31 doi:10.1183/09031936.00008910.
• 16 Borland R, Li L, Driezen P. et al. Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction 2012; 107: 197-205 doi:10.1111/j.1360-0443.2011.03636.x
• 17 Blau A, Weiß JM, Kurzeja A. et al. Erste Erfahrungen mit multimodaler stationärer Behandlung zur Tabakentwöhnung (OPS 9–501). Pneumologie 2017; 71: S115